Difference between revisions of "Role of ubiquitination"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
Line 565: Line 565:
 
(.//.)<html><!--Pop-up for: Methylglyoxal !Pop-up-->
 
(.//.)<html><!--Pop-up for: Methylglyoxal !Pop-up-->
 
<div class="1J1D8B0LY-77N6FX-5FN" style="display:none;">
 
<div class="1J1D8B0LY-77N6FX-5FN" style="display:none;">
 +
  
  
Line 572: Line 573:
 
</div>(...)<!--Pop-up for: E2F !Pop-up-->
 
</div>(...)<!--Pop-up for: E2F !Pop-up-->
 
<div class="1HXDY3N30-SXZ26V-89M" style="display:none;">
 
<div class="1HXDY3N30-SXZ26V-89M" style="display:none;">
 +
  
  
Line 579: Line 581:
 
</div>(...)<!--Pop-up for: Ras !Pop-up-->
 
</div>(...)<!--Pop-up for: Ras !Pop-up-->
 
<div class="1HXF3TMQM-73NBC5-FW0" style="display:none;">
 
<div class="1HXF3TMQM-73NBC5-FW0" style="display:none;">
 +
  
  
Line 586: Line 589:
 
</div>(...)<!--Pop-up for: ATR !Pop-up-->
 
</div>(...)<!--Pop-up for: ATR !Pop-up-->
 
<div class="1N9P66C3N-1KWKJKJ-1ZB3" style="display:none;">
 
<div class="1N9P66C3N-1KWKJKJ-1ZB3" style="display:none;">
 +
  
  
Line 593: Line 597:
 
</div>(...)<!--Pop-up for: Proliferation !Pop-up-->
 
</div>(...)<!--Pop-up for: Proliferation !Pop-up-->
 
<div class="1HXF3W5MJ-D3H95R-FXG" style="display:none;">
 
<div class="1HXF3W5MJ-D3H95R-FXG" style="display:none;">
 +
  
  
Line 600: Line 605:
 
</div>(...)<!--Pop-up for: Poliubiquitination of  Ubiquitin ligase CHIP by E3 !Pop-up-->
 
</div>(...)<!--Pop-up for: Poliubiquitination of  Ubiquitin ligase CHIP by E3 !Pop-up-->
 
<div class="1J1D8K6B5-17RSFTK-5JW" style="display:none;">
 
<div class="1J1D8K6B5-17RSFTK-5JW" style="display:none;">
 +
  
  
Line 607: Line 613:
 
</div>(...)<!--Pop-up for: Availability of damaged DNA For repair complexes !Pop-up-->
 
</div>(...)<!--Pop-up for: Availability of damaged DNA For repair complexes !Pop-up-->
 
<div class="1HXDX8QW4-8CH6YX-7M9" style="display:none;">
 
<div class="1HXDX8QW4-8CH6YX-7M9" style="display:none;">
 +
  
  
Line 614: Line 621:
 
</div>(...)<!--Pop-up for: Transcription of adaptation  to hypoxia genes !Pop-up-->
 
</div>(...)<!--Pop-up for: Transcription of adaptation  to hypoxia genes !Pop-up-->
 
<div class="1HXLM05XC-1FSPCXC-17T" style="display:none;">
 
<div class="1HXLM05XC-1FSPCXC-17T" style="display:none;">
 +
  
  
Line 621: Line 629:
 
</div>(...)<!--Pop-up for: FOXO1 deacetylation !Pop-up-->
 
</div>(...)<!--Pop-up for: FOXO1 deacetylation !Pop-up-->
 
<div class="1J2TTSY2L-Z3PR1X-12T" style="display:none;">
 
<div class="1J2TTSY2L-Z3PR1X-12T" style="display:none;">
 +
  
  
Line 628: Line 637:
 
</div>(...)<!--Pop-up for: EGF-R !Pop-up-->
 
</div>(...)<!--Pop-up for: EGF-R !Pop-up-->
 
<div class="1HXF3TF9N-2CNRBZM-FVR" style="display:none;">
 
<div class="1HXF3TF9N-2CNRBZM-FVR" style="display:none;">
 +
  
  
Line 635: Line 645:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of p21 and p27 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of p21 and p27 !Pop-up-->
 
<div class="1HXF1DZW9-1N3N3CF-CCH" style="display:none;">
 
<div class="1HXF1DZW9-1N3N3CF-CCH" style="display:none;">
 +
  
  
Line 642: Line 653:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase complex  Rad6-Rad18 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase complex  Rad6-Rad18 !Pop-up-->
 
<div class="1HXDYCP8F-2BZCX14-8VY" style="display:none;">
 
<div class="1HXDYCP8F-2BZCX14-8VY" style="display:none;">
 +
  
  
Line 649: Line 661:
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
<div class="1HXDYPJ1C-RC1Z03-8X5" style="display:none;">
 
<div class="1HXDYPJ1C-RC1Z03-8X5" style="display:none;">
 +
  
  
Line 656: Line 669:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of HIF-1a !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of HIF-1a !Pop-up-->
 
<div class="1HXLLVYXK-YD59DQ-15R" style="display:none;">
 
<div class="1HXLLVYXK-YD59DQ-15R" style="display:none;">
 +
  
  
Line 663: Line 677:
 
</div>(...)<!--Pop-up for: DNA damage !Pop-up-->
 
</div>(...)<!--Pop-up for: DNA damage !Pop-up-->
 
<div class="1HXDXCP6L-1JPNVC5-7R3" style="display:none;">
 
<div class="1HXDXCP6L-1JPNVC5-7R3" style="display:none;">
 +
  
  
Line 670: Line 685:
 
</div>(...)<!--Pop-up for: Monoubiquitination by ligase Cbl !Pop-up-->
 
</div>(...)<!--Pop-up for: Monoubiquitination by ligase Cbl !Pop-up-->
 
<div class="1HXF3XKMD-1MDXYWM-FZ1" style="display:none;">
 
<div class="1HXF3XKMD-1MDXYWM-FZ1" style="display:none;">
 +
  
  
Line 677: Line 693:
 
</div>(...)<!--Pop-up for: ATP-dependent  Chromatin remodeling !Pop-up-->
 
</div>(...)<!--Pop-up for: ATP-dependent  Chromatin remodeling !Pop-up-->
 
<div class="1HXDX70DD-C3RG63-7L2" style="display:none;">
 
<div class="1HXDX70DD-C3RG63-7L2" style="display:none;">
 +
  
  
Line 684: Line 701:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of FOXO1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of FOXO1 !Pop-up-->
 
<div class="1J2TTVWV5-1XB3QXN-15M" style="display:none;">
 
<div class="1J2TTVWV5-1XB3QXN-15M" style="display:none;">
 +
  
  
Line 691: Line 709:
 
</div>(...)<!--Pop-up for: DNA repair !Pop-up-->
 
</div>(...)<!--Pop-up for: DNA repair !Pop-up-->
 
<div class="1HXDZ4FX8-1VG5BFM-92S" style="display:none;">
 
<div class="1HXDZ4FX8-1VG5BFM-92S" style="display:none;">
 +
  
  
Line 698: Line 717:
 
</div>(...)<!--Pop-up for: Normoxia !Pop-up-->
 
</div>(...)<!--Pop-up for: Normoxia !Pop-up-->
 
<div class="1HXLLS50M-1PPGMX8-11F" style="display:none;">
 
<div class="1HXLLS50M-1PPGMX8-11F" style="display:none;">
 +
  
  
Line 705: Line 725:
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
</div>(...)<!--Pop-up for: PCNA !Pop-up-->
 
<div class="1N9P5YMFF-15HT175-1Z1Z" style="display:none;">
 
<div class="1N9P5YMFF-15HT175-1Z1Z" style="display:none;">
 +
  
  
Line 712: Line 733:
 
</div>(...)<!--Pop-up for: ARF !Pop-up-->
 
</div>(...)<!--Pop-up for: ARF !Pop-up-->
 
<div class="1HXF0TXZ0-2BJ3NZN-BJY" style="display:none;">
 
<div class="1HXF0TXZ0-2BJ3NZN-BJY" style="display:none;">
 +
  
  
Line 719: Line 741:
 
</div>(...)<!--Pop-up for: Disturbance of tissue resistance to hypoxia !Pop-up-->
 
</div>(...)<!--Pop-up for: Disturbance of tissue resistance to hypoxia !Pop-up-->
 
<div class="1J1D8PQ19-MN9P7R-5P6" style="display:none;">
 
<div class="1J1D8PQ19-MN9P7R-5P6" style="display:none;">
 +
  
  
Line 726: Line 749:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of hTERT !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of hTERT !Pop-up-->
 
<div class="1HXDZVLBH-HRNZM1-9PT" style="display:none;">
 
<div class="1HXDZVLBH-HRNZM1-9PT" style="display:none;">
 +
  
  
Line 733: Line 757:
 
</div>(...)<!--Pop-up for: Cell proliferation !Pop-up-->
 
</div>(...)<!--Pop-up for: Cell proliferation !Pop-up-->
 
<div class="1HXF261VH-3SS0BX-D11" style="display:none;">
 
<div class="1HXF261VH-3SS0BX-D11" style="display:none;">
 +
  
  
Line 740: Line 765:
 
</div>(...)<!--Pop-up for: SIRT1 !Pop-up-->
 
</div>(...)<!--Pop-up for: SIRT1 !Pop-up-->
 
<div class="1J2TTSH03-9498TK-12B" style="display:none;">
 
<div class="1J2TTSH03-9498TK-12B" style="display:none;">
 +
  
  
Line 747: Line 773:
 
</div>(...)<!--Pop-up for: MAPK !Pop-up-->
 
</div>(...)<!--Pop-up for: MAPK !Pop-up-->
 
<div class="1HXF3TW1Q-23JXDZC-FWS" style="display:none;">
 
<div class="1HXF3TW1Q-23JXDZC-FWS" style="display:none;">
 +
  
  
Line 754: Line 781:
 
</div>(...)<!--Pop-up for: Cyclin E/Cdk2 !Pop-up-->
 
</div>(...)<!--Pop-up for: Cyclin E/Cdk2 !Pop-up-->
 
<div class="1HXF15RQR-1KBC5BM-C6K" style="display:none;">
 
<div class="1HXF15RQR-1KBC5BM-C6K" style="display:none;">
 +
  
  
Line 761: Line 789:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of Pin2/TRF1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasomal  Degradation of Pin2/TRF1 !Pop-up-->
 
<div class="1HXF1P942-2BF86CX-CN0" style="display:none;">
 
<div class="1HXF1P942-2BF86CX-CN0" style="display:none;">
 +
  
  
Line 768: Line 797:
 
</div>(...)<!--Pop-up for: E3 ubiquitin  Ligase complex  BRCA1/BARD1 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin  Ligase complex  BRCA1/BARD1 !Pop-up-->
 
<div class="1HXDX5L49-77W2CW-7HY" style="display:none;">
 
<div class="1HXDX5L49-77W2CW-7HY" style="display:none;">
 +
  
  
Line 775: Line 805:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase VHL !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase VHL !Pop-up-->
 
<div class="1HXLLTPY9-V8MC72-153" style="display:none;">
 
<div class="1HXLLTPY9-V8MC72-153" style="display:none;">
 +
  
  
Line 782: Line 813:
 
</div>(...)<!--Pop-up for: Р53 !Pop-up-->
 
</div>(...)<!--Pop-up for: Р53 !Pop-up-->
 
<div class="1HXDXPP3Z-1K7XJS9-7ZK" style="display:none;">
 
<div class="1HXDXPP3Z-1K7XJS9-7ZK" style="display:none;">
 +
  
  
Line 789: Line 821:
 
</div>(...)<!--Pop-up for: Cyclin A/Cdk2 !Pop-up-->
 
</div>(...)<!--Pop-up for: Cyclin A/Cdk2 !Pop-up-->
 
<div class="1N9P55MTN-4H4V8F-1YRJ" style="display:none;">
 
<div class="1N9P55MTN-4H4V8F-1YRJ" style="display:none;">
 +
  
  
Line 796: Line 829:
 
</div>(...)<!--Pop-up for: ubiquitination !Pop-up-->
 
</div>(...)<!--Pop-up for: ubiquitination !Pop-up-->
 
<div class="1NLC2KCGW-SKR5JN-38F" style="display:none;">
 
<div class="1NLC2KCGW-SKR5JN-38F" style="display:none;">
 +
  
  
Line 803: Line 837:
 
</div>(...)<!--Pop-up for: Complex 9-1-1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Complex 9-1-1 !Pop-up-->
 
<div class="1HXDYQ1VX-P0G5CN-8Y9" style="display:none;">
 
<div class="1HXDYQ1VX-P0G5CN-8Y9" style="display:none;">
 +
  
  
Line 810: Line 845:
 
</div>(...)<!--Pop-up for: Transcription of  proliferation genes !Pop-up-->
 
</div>(...)<!--Pop-up for: Transcription of  proliferation genes !Pop-up-->
 
<div class="1HXDY473R-160M3Z0-8C5" style="display:none;">
 
<div class="1HXDY473R-160M3Z0-8C5" style="display:none;">
 +
  
  
Line 817: Line 853:
 
</div>(...)<!--Pop-up for: Chk2 kinase !Pop-up-->
 
</div>(...)<!--Pop-up for: Chk2 kinase !Pop-up-->
 
<div class="1HXDXX01M-SPR3HQ-82K" style="display:none;">
 
<div class="1HXDXX01M-SPR3HQ-82K" style="display:none;">
 +
  
  
Line 824: Line 861:
 
</div>(...)<!--Pop-up for: XPC !Pop-up-->
 
</div>(...)<!--Pop-up for: XPC !Pop-up-->
 
<div class="1N9P5YC6Y-WZZ1KZ-1Z1D" style="display:none;">
 
<div class="1N9P5YC6Y-WZZ1KZ-1Z1D" style="display:none;">
 +
  
  
Line 831: Line 869:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
<div class="1HXDZTC5L-1T2SN4H-9N1" style="display:none;">
 
<div class="1HXDZTC5L-1T2SN4H-9N1" style="display:none;">
 +
  
  
Line 838: Line 877:
 
</div>(...)<!--Pop-up for: Ligand binding !Pop-up-->
 
</div>(...)<!--Pop-up for: Ligand binding !Pop-up-->
 
<div class="1HXF413M8-1ZWD9C0-G37" style="display:none;">
 
<div class="1HXF413M8-1ZWD9C0-G37" style="display:none;">
 +
  
  
Line 845: Line 885:
 
</div>(...)<!--Pop-up for: Transition to  Cell cycle S-phase !Pop-up-->
 
</div>(...)<!--Pop-up for: Transition to  Cell cycle S-phase !Pop-up-->
 
<div class="1HXF2PNF5-T888QY-F0C" style="display:none;">
 
<div class="1HXF2PNF5-T888QY-F0C" style="display:none;">
 +
  
  
Line 852: Line 893:
 
</div>(...)<!--Pop-up for: Phosphorylation of inhibitor of cyclin-dependent  Kinases p21 and p27 !Pop-up-->
 
</div>(...)<!--Pop-up for: Phosphorylation of inhibitor of cyclin-dependent  Kinases p21 and p27 !Pop-up-->
 
<div class="1HXF16LX4-26J48HP-C7M" style="display:none;">
 
<div class="1HXF16LX4-26J48HP-C7M" style="display:none;">
 +
  
  
Line 859: Line 901:
 
</div>(...)<!--Pop-up for: DDB2 !Pop-up-->
 
</div>(...)<!--Pop-up for: DDB2 !Pop-up-->
 
<div class="1N9P5Y33L-1FNMXTX-1Z18" style="display:none;">
 
<div class="1N9P5Y33L-1FNMXTX-1Z18" style="display:none;">
 +
  
  
Line 866: Line 909:
 
</div>(...)<!--Pop-up for: Proteasome degradation of HIF-1a !Pop-up-->
 
</div>(...)<!--Pop-up for: Proteasome degradation of HIF-1a !Pop-up-->
 
<div class="1J1D8NGZC-20SQKFW-5M6" style="display:none;">
 
<div class="1J1D8NGZC-20SQKFW-5M6" style="display:none;">
 +
  
  
Line 873: Line 917:
 
</div>(...)<!--Pop-up for: Histone H2AX  Monoubiquitination !Pop-up-->
 
</div>(...)<!--Pop-up for: Histone H2AX  Monoubiquitination !Pop-up-->
 
<div class="1HXDX5TVJ-1TX6BB3-7JG" style="display:none;">
 
<div class="1HXDX5TVJ-1TX6BB3-7JG" style="display:none;">
 +
  
  
Line 880: Line 925:
 
</div>(...)<!--Pop-up for: Adducts with  transcription  factor Hif-1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Adducts with  transcription  factor Hif-1 !Pop-up-->
 
<div class="1J1D8GLS6-N6V8MY-5GP" style="display:none;">
 
<div class="1J1D8GLS6-N6V8MY-5GP" style="display:none;">
 +
  
  
Line 887: Line 933:
 
</div>(...)<!--Pop-up for: Binding of Rb !Pop-up-->
 
</div>(...)<!--Pop-up for: Binding of Rb !Pop-up-->
 
<div class="1HXDY3B19-XD74WC-88N" style="display:none;">
 
<div class="1HXDY3B19-XD74WC-88N" style="display:none;">
 +
  
  
Line 894: Line 941:
 
</div>(...)<!--Pop-up for: Lysosomal degradation of EGF-R !Pop-up-->
 
</div>(...)<!--Pop-up for: Lysosomal degradation of EGF-R !Pop-up-->
 
<div class="1HXF40D8M-1LTSYPY-G1J" style="display:none;">
 
<div class="1HXF40D8M-1LTSYPY-G1J" style="display:none;">
 +
  
  
Line 901: Line 949:
 
</div>(...)<!--Pop-up for: DNA repair genes !Pop-up-->
 
</div>(...)<!--Pop-up for: DNA repair genes !Pop-up-->
 
<div class="1HXDXQ0P6-1FHWYSW-80J" style="display:none;">
 
<div class="1HXDXQ0P6-1FHWYSW-80J" style="display:none;">
 +
  
  
Line 908: Line 957:
 
</div>(...)<!--Pop-up for: Nucleoplasmin/B23 !Pop-up-->
 
</div>(...)<!--Pop-up for: Nucleoplasmin/B23 !Pop-up-->
 
<div class="1HXDY14S5-1LD6P1Q-86K" style="display:none;">
 
<div class="1HXDY14S5-1LD6P1Q-86K" style="display:none;">
 +
  
  
Line 915: Line 965:
 
</div>(...)<!--Pop-up for: ATM !Pop-up-->
 
</div>(...)<!--Pop-up for: ATM !Pop-up-->
 
<div class="1HXDXBJY6-2013R63-7PX" style="display:none;">
 
<div class="1HXDXBJY6-2013R63-7PX" style="display:none;">
 +
  
  
Line 922: Line 973:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase MKRN1 !Pop-up-->
 
<div class="1HXF0TRRP-14KR8HB-BJS" style="display:none;">
 
<div class="1HXF0TRRP-14KR8HB-BJS" style="display:none;">
 +
  
  
Line 929: Line 981:
 
</div>(...)<!--Pop-up for: Telomerase complex destruction !Pop-up-->
 
</div>(...)<!--Pop-up for: Telomerase complex destruction !Pop-up-->
 
<div class="1HXDZXGR8-11H1VXM-9RL" style="display:none;">
 
<div class="1HXDZXGR8-11H1VXM-9RL" style="display:none;">
 +
  
  
Line 936: Line 989:
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase Skp2 !Pop-up-->
 
</div>(...)<!--Pop-up for: E3 ubiquitin ligase Skp2 !Pop-up-->
 
<div class="1J2TTV0QY-1S75YF7-14X" style="display:none;">
 
<div class="1J2TTV0QY-1S75YF7-14X" style="display:none;">
 +
  
  
Line 943: Line 997:
 
</div>(...)<!--Pop-up for: Cellular senescence !Pop-up-->
 
</div>(...)<!--Pop-up for: Cellular senescence !Pop-up-->
 
<div class="1HXF423NB-1PLD05D-G51" style="display:none;">
 
<div class="1HXF423NB-1PLD05D-G51" style="display:none;">
 +
  
  
Line 950: Line 1,005:
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of cyclin D1 !Pop-up-->
 
</div>(...)<!--Pop-up for: Ubiquitination and proteasome  Degradation of cyclin D1 !Pop-up-->
 
<div class="1HXF2DVY7-2C75KYW-DK4" style="display:none;">
 
<div class="1HXF2DVY7-2C75KYW-DK4" style="display:none;">
 +
  
  
Line 957: Line 1,013:
 
</div>(...)<!--Pop-up for: Telomere lengthening !Pop-up-->
 
</div>(...)<!--Pop-up for: Telomere lengthening !Pop-up-->
 
<div class="1HXF23LXY-TG4R0T-CQW" style="display:none;">
 
<div class="1HXF23LXY-TG4R0T-CQW" style="display:none;">
 +
  
  
Line 964: Line 1,021:
 
</div>(...)<!--Pop-up for: High levels of glucose !Pop-up-->
 
</div>(...)<!--Pop-up for: High levels of glucose !Pop-up-->
 
<div class="1J1D89CBX-J65J0B-59H" style="display:none;">
 
<div class="1J1D89CBX-J65J0B-59H" style="display:none;">
 +
  
  
Line 971: Line 1,029:
 
</div>(...)<!--Pop-up for:  E3 ubiquitin ligase SCF-Skp2 !Pop-up-->
 
</div>(...)<!--Pop-up for:  E3 ubiquitin ligase SCF-Skp2 !Pop-up-->
 
<div class="1HXF1C9SL-1NY06WB-CBC" style="display:none;">
 
<div class="1HXF1C9SL-1NY06WB-CBC" style="display:none;">
 +
  
  
Line 978: Line 1,037:
 
</div>(...)<!--Pop-up for: Telomere shortening !Pop-up-->
 
</div>(...)<!--Pop-up for: Telomere shortening !Pop-up-->
 
<div class="1HXF24Q2K-K603LY-CSB" style="display:none;">
 
<div class="1HXF24Q2K-K603LY-CSB" style="display:none;">
 +
  
  
Line 985: Line 1,045:
 
</div>(...)<!--Pop-up for: SCF Fbx4/alphaB -crystalline E3 ubiquitin  ligase complex !Pop-up-->
 
</div>(...)<!--Pop-up for: SCF Fbx4/alphaB -crystalline E3 ubiquitin  ligase complex !Pop-up-->
 
<div class="1HXF1NHBS-1WFWH9C-CMN" style="display:none;">
 
<div class="1HXF1NHBS-1WFWH9C-CMN" style="display:none;">
 +
  
  

Revision as of 13:58, 26 February 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.